🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Congratulations to Yale IM Traditional Residency Program alumnus, Manan Pareek, MD, PhD, FAHA, FESC! Yale Internal Medicine Yale Cardiology

Very delighted to represent CTCPR Trials & CIRL and RigsHeart 🫀🚨 and discuss management of cardiovascular risk in patients with obesity alongside Professor Nikolaus Marx from Aachen, Germany during the Novo Nordisk lunch symposium at the #NBCC in Copenhagen!

Novel #ArtificialIntelligence model using electrocardiogram for detecting acute myocardial infarction needing revascularisation ow.ly/oXhS50VXyXx #EHJDigital #eHealth Nico Bruining EiC EHJ Digital Health rafavidalperez Folkert Asselbergs Ruben Casado Arroyo

#NBCC 2025 🇩🇰🇸🇪🇳🇴🇫🇮🇮🇸🇱🇻🇪🇪🇱🇹 🔥 Great sessions on valve disease, ACS, sports cardiology and more 🔥 Young investigator 🔥 Meeting with new and old colleagues 🔥Perfect setting at TIVOLI Hotel in Copenhagen 🔥Interesting discussions Thanks to all speakers, chairs, and organisers

Had a blast co-chairing today's #NBCC Dansk Cardiologisk Selskab (DCS) session on MI in the elderly with Ashkan Eftekhari and Eva Prescott from European Society of Cardiology - fantastic panel consisting of rockstars Professor Vijay Kunadian Thomas Engstrøm Rikke Sørensen Lene Holmvang! Huge thanks to Reza Jabbari Christina Byrne!

Graduated with an MSc in Clinical Trials from University of Oxford. Grateful to the European Society of Cardiology Oxford Population Health (OxPop). Will always cherish the friendship and fun we had during this journey. Thank you Manan Pareek, MD, MSc, PhD, FAHA, FESC Mihaela Roxana Popescu Ahmed Teebi, MD MPH🗝️

Excited that #PanEcho is now published in JAMA Kudos to Greg Holste Evangelos K. Oikonomou for leading this incredible effort! Now also validated on ED POCUS studies + RVNet+ (Thx Attila Kovacs & Marton Tokodi for joining us) See 🧵 below for details! jamanetwork.com/journals/jama/…

Please find the most recent publication from CTCPR Trials & CIRL in JAMA 👇 In this randomized experiment embedded within the recruitment of the world largest flu vaccine trial (DANFLU-2 trial), we testet which invitation letter would increase the likelihood of trial participation

The very first paper from DANFLU-2 - the largest individually randomized influenza vaccine RCT ever conducted – is officially out in JAMA: An RCT embedded into the recruitment phase testing the impact of recruitment letter design and color scheme. ja.ma/3Gfixqa

We randomized almost 1 million >65 yo to receive 1 of 3 different recruitment letter formats with 1 of 3 different color schemes in a 3x3 factorial design. Primary outcome: enrollment in the trial.

Check out our webinar on various aspects of cardio-oncology recorded yesterday in Stockholm: dagensmedisin.no/dmarena/nordic… Dan Atar CTCPR Trials & CIRL RigsHeart 🫀🚨

If you have research on Inflammation in acute MI let me, Manan Pareek, MD, MSc, PhD, FAHA, FESC or Tarek Bekfani, MD, (Priv.-Doz.), MSc, FESC, FHFA know about it - Exploring the impact of Inflammatory processes on the course of Acute Myocardial Infarction: Pathways and Therapies Frontiers in Cardiovascular Medicine frontiersin.org/researchtopic/…

Vaccination as a new form of cardiovascular prevention: a European Society of Cardiology clinical consensus statement. Read more in #EHJ 👉 ow.ly/teuC50WiZym Rocco Montone EHJ Editor-in-Chief

In our post hoc analysis of the randomized STEP trial, ARBs and CCBs appeared more favorable for reducing composite cardiovascular outcomes than diuretics and beta-blockers. Full article here (open access): bmcmedicine.biomedcentral.com/articles/10.11… CTCPR Trials & CIRL RigsHeart 🫀🚨

Confounders, Effect Modifiers, and Mediators: Dealing With “Third Variables” in Cardiovascular Epidemiology: Circulation 🥸 Epi 101 from PhD times; nice work from the TIMI group. 😱 Few definitions below; always good to understand the difference between these 👇👇👇

New CTCPR Trials & CIRL study: Elevated hs-troponin T in PSVT without heart disease means higher 30-day mortality. ▪️ 65%+ had raised troponin ▪️ 30-day death: 2.4% vs <0.01% ▪️ No long-term impact 🫀 Useful for early risk assessment 🔗pubmed.ncbi.nlm.nih.gov/39549773/

#ArtificialIntelligence based accurate myocardial infarction mapping using 12-lead electrocardiography 👉 ow.ly/TqUp50WmZl4 #EHJDigital #eHealth Nico Bruining EiC EHJ Digital Health rafavidalperez Folkert Asselbergs Ruben Casado Arroyo

Great debate: artificial intelligence will replace much of what cardiologists do. Which is your opinion? Read more in the @EHJ doi.org/10.1093/eurhea… #ArtificialIntelligence #Cardiology @ESCardio European Society of Cardiology Journals

📌 Do statins play a role in primary CVD prevention among apparently healthy adults? 🔍 New evidence from a large Danish cohort study—read more ⬇️ shorturl.at/2RQhr EJPC Editor-in-Chief Victor Aboyans Silvia Castelletti Francesco Perone Buket Akıncı Vasiliki Tsampasian